FDA Approved: RITUXAN HYCELA — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Rituxan HYCELA (rituximab and hyaluronidase) from Genentech, expanding its approval through a supplemental submi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• Rituxan Hycela (rituximab/hyaluronidase)

Snippet

SUPPL AP for RITUXAN HYCELA (RITUXIMAB AND HYALURONIDASE)